Explore the Global Immuno Oncology Assay Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Immuno Oncology Assay Market

Key Insight

Reagents and antibodies will lead immuno oncology assay sales through 2036 with 37.6% of the product segment in 2026. The market was valued at USD 6.30 billion in 2025 and is expected to be worth USD 21.49 billion by 2036, creating an incremental opportunity of USD 14.44 billion.

May 20, 2026

Anurag Sharma

315 Pages

Cite this Report

Immuno Oncology Assay Market

https://www.futuremarketinsights.com/reports/immuno-oncology-assay-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Agilent Technologies
Bio-Rad Laboratories
Charles River Laboratories
F. Hoffmann-La Roche Ag
Illumina
NanoString Technologies
PerkinElmer
QIAGEN N.V
Sartorius AG
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Immuno Oncology Assay Market

Key Players

Similar Industry Reports